Health and Fitness Health and Fitness
Tue, July 26, 2011
[ 05:00 PM ] - Market Wire
Perrigo Closes Acquisition of Paddock Labs
[ 02:00 PM ] - Market Wire
Mary Sammons Joins Magellan Health Services Board of Directors
[ 02:00 PM ] - Market Wire
GenMark Diagnostics Schedules Second Quarter 2011 .. al Results and Conference Call for August 5, 2011
[ 02:00 PM ] - Market Wire
Teleflex Incorporated Signs New Agreement with Pr .. us Access, Peripheral Inserted Central Access and
[ 01:34 PM ] - Market Wire
CytRx Announces Public Offering
[ 01:30 PM ] - Market Wire
Geron Announces Conference Call to Discuss Second Quarter Financial Results and Highlights
[ 01:05 PM ] - Market Wire
AMAG Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2011
[ 01:01 PM ] - Market Wire
ArthroCare Receives FDA Clearance for SpeedFixa" Suture System
[ 10:44 AM ] - Market Wire
Merck Announces Fourth Quarter 2011 Dividend
[ 10:32 AM ] - Market Wire
Covidien publiceert derdekwartaalcijfers
[ 10:30 AM ] - Market Wire
Cubist Pharmaceuticals to Present at August 2011 Investor Conferences
[ 08:34 AM ] - Market Wire
DaVita Reports on Corporate Social Responsibility Efforts
[ 07:46 AM ] - Market Wire
Electromed, Inc. Names William Eckles to Its Board of Directors
[ 07:03 AM ] - Market Wire
Amedisys Welcomes Todd Roscoe as Vice President of Managed Care
[ 06:30 AM ] - Market Wire
Adamis Receives Another Milestone Payment
[ 05:30 AM ] - Market Wire
Impax Pharmaceuticals Completes Enrollment in ASC .. Phase III Trial of IPX066 in Parkinsona?s Disease
[ 05:00 AM ] - Market Wire
Amyris Fornecer Diesel de Cana para "nibus no Rio de Janeiro
[ 05:00 AM ] - Market Wire
Amyris to Supply Rio de Janeiro Buses with Renewable Diesel from Sugarcane
[ 04:46 AM ] - Market Wire
Biogen Idec en Swedish Orphan Biovitrum presenter .. et langdurig werkzame recombinante factor VIII ti
[ 04:30 AM ] - Market Wire
Interim Data from Phase 2 Study of Combination Re .. CIVEKa" Suggest Potential to Treat Genotype 1 Hep
[ 04:30 AM ] - Market Wire
Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas
[ 04:15 AM ] - Market Wire
Biogen Idec Reports Second Quarter 2011 Results
[ 04:15 AM ] - Market Wire
Ligand Partner GlaxoSmithKline Receives Positive .. LE1 Study in Hepatitis C-Related Thrombocytopenia
[ 04:11 AM ] - Market Wire
Biogen Idec y Swedish Orphan Biovitrum presentan .. factor VIII recombinante con accin duradera en la
[ 04:00 AM ] - Market Wire
Arrowhead Research Announces Oncology Expert Timo .. Triche to Join Calando Scientific Advisory Board
[ 04:00 AM ] - Market Wire
Dyax Corp. and Kadmon Corporation Announce Antibody Library License Agreement
[ 04:00 AM ] - Market Wire
American Anesthesiology Announces the Acquisition of Group Practice Based in Palm Beach County, FL
[ 03:15 AM ] - Market Wire
Biogen Idec et Swedish Orphan Biovitrum pr©sente .. ement avec le facteur VIII recombinant action pro
[ 02:58 AM ] - Market Wire
Biogen Idec und Swedish Orphan Biovitrum legen Da .. wirkenden rekombinanten Faktor VIII auf der Tagun
Mon, July 25, 2011
[ 09:30 PM ] - Market Wire
Biogen Idec e Swedish Orphan Biovitrum presentano .. durata con fattore VIII ricombinante alla riunion

Biogen Idec e Swedish Orphan Biovitrum presentano dati sulla terapia di lunga durata con fattore VIII ricombinante alla riunion


Published on 2011-07-25 22:20:20 - Market Wire
  Print publication without navigation


KYOTO, Giappone--([ BUSINESS WIRE ])--[ Biogen Idec ](NASDAQ: BIIB) e[ Swedish Orphan Biovitrum ](STO: SOBI) hanno annunciato in data odierna i dati di uno studio di fase 1/2a indicanti che la proteina di fusione Fc costituita da fattore VIII totalmente ricombinante di lunga durata dell'azienda (rFVIIIFc) era ben tollerata e ha dimostrato un aumento di circa 1,7 volte dell'emivita rispetto ad Advate® (fattore ricombinante anti-emofilico, metodo senza plasma/albumina, rFVIII), prodotto disponibile commercialmente a base di fattore VIII, in 16 pazienti trattati previamente affetti da emofilia A grave.

Galleria Fotografica/Multimediale Disponibile: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6805603&lang=it ]

Contributing Sources